161 related articles for article (PubMed ID: 38243058)
1. Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer.
Liu Y; Xu Y; Li X; Chen M; Wang X; Zhang N; Zhang H; Zhang Z
NPJ Precis Oncol; 2024 Jan; 8(1):13. PubMed ID: 38243058
[TBL] [Abstract][Full Text] [Related]
2. Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma.
Liu Y; Zhang H; Xu Y; Liu YZ; Al-Adra DP; Yeh MM; Zhang Z
Cancer Inform; 2023; 22():11769351231190477. PubMed ID: 37577174
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
4. Machine learning and network-based models to identify genetic risk factors to the progression and survival of colorectal cancer.
Hossain MJ; Chowdhury UN; Islam MB; Uddin S; Ahmed MB; Quinn JMW; Moni MA
Comput Biol Med; 2021 Aug; 135():104539. PubMed ID: 34153790
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning-Based Identification of Colon Cancer Candidate Diagnostics Genes.
Koppad S; Basava A; Nash K; Gkoutos GV; Acharjee A
Biology (Basel); 2022 Feb; 11(3):. PubMed ID: 35336739
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics Analysis of Prognosis-Related Genes and Expression of CXCL8 in Colorectal Cancer.
Yao Z; Pan X; Chen W; Pei Y; Chen C; Huang Y; Liu S; Liu Y
Biomed Res Int; 2022; 2022():3149887. PubMed ID: 35845924
[TBL] [Abstract][Full Text] [Related]
8. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
9. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a pyroptosis-related prognostic model for colorectal cancer.
Li R; Zhang S; Liu G
Funct Integr Genomics; 2022 Dec; 23(1):21. PubMed ID: 36564624
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers for neoplastic progression from ulcerative colitis to colorectal cancer: a systems biology approach.
Shahnazari M; Afshar S; Emami MH; Amini R; Jalali A
Sci Rep; 2023 Feb; 13(1):3413. PubMed ID: 36854781
[TBL] [Abstract][Full Text] [Related]
13. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer.
Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A
BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803
[TBL] [Abstract][Full Text] [Related]
14. Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis.
Li M; Liu Z; Song J; Wang T; Wang H; Wang Y; Guo J
Front Mol Biosci; 2022; 9():791249. PubMed ID: 35300114
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key MicroRNAs and Genes between Colorectal Adenoma and Colorectal Cancer via Deep Learning on GEO Databases and Bioinformatics.
Zhang X; Jin M; Liu F; Qu H; Chen C
Contrast Media Mol Imaging; 2023; 2023():6457152. PubMed ID: 36793496
[TBL] [Abstract][Full Text] [Related]
16. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
[TBL] [Abstract][Full Text] [Related]
17. Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker.
Zhang H; Du Y; Wang Z; Lou R; Wu J; Feng J
Biochem Res Int; 2019; 2019():6469420. PubMed ID: 31467713
[TBL] [Abstract][Full Text] [Related]
18. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
19. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
20. Weighted gene co-expression network analysis combined with machine learning validation to identify key hub biomarkers in colorectal cancer.
Guo C; Xie B; Liu Q
Funct Integr Genomics; 2022 Dec; 23(1):24. PubMed ID: 36576616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
